Many Investors Wouldn't Touch This Stock With a 10-Foot Pole Last Year. Here's Why It's a Buy in 2023.The Motley Fool • 01/06/23
Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated TherapeuticsAccesswire • 01/05/23
Moderna Bolsters Its Vaccine Pipeline With $85 Million Deal for Biotech Firm OriCiroBarrons • 01/04/23
Moderna to Provide Business and Pipeline Updates at the 2023 J.P. Morgan Healthcare ConferenceAccesswire • 01/03/23
Tesla is not alone: 18 (and a half) other big stocks are headed for their worst year on recordMarket Watch • 12/30/22
Stock Market Gets More Jittery As Bond Yields Jump Again; Sellers Hit Tesla, Moderna, Nvidia HardInvestors Business Daily • 12/27/22